ロード中...
The Fallacy of Average: How Using HbA(1c) Alone to Assess Glycemic Control Can Be Misleading
HbA(1c) is a valuable metric for comparing treatment groups in a randomized trial, for assessing glycemic trends in a population over time, or for cross-sectional comparisons of glycemic control in different populations. However, what is not widely appreciated is that HbA(1c) may not be a good indic...
保存先:
| 出版年: | Diabetes Care |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Diabetes Association
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5521971/ https://ncbi.nlm.nih.gov/pubmed/28733374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc17-0636 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|